Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea · Delayed Price · Currency is KRW 24,800
+50 (0.20%)
Aug 29, 2025, 9:29 AM KST
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 248.15 billion as of August 28, 2025. Its market cap has increased by 64.94% in one year.
Market Cap
248.15B
Enterprise Value
204.31B
Revenue
7.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
24,800.00
Market Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has decreased from 291.82B to 248.15B, a decrease of -14.96%. That is a compound annual growth rate of -1.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 248.15B | 34.99% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | 566.53B | 52.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.60T |
| Celltrion | 37.63T |
| ALTEOGEN | 22.61T |
| Yuhan | 8,694.51B |
| SK Biopharmaceuticals | 7,893.98B |
| Peptron | 7,466.80B |
| PharmaResearch | 7,314.31B |
| LigaChem Biosciences | 5,379.81B |